BioSpace News Archive

Drug Development

Fibrocell Announces Submission of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma

The FDA has granted Orphan Drug Designation to FCX-013 for the treatment of localized scleroderma.

February 5, 2018

·

6 min read

Business

Bio-Path Holdings Appoints Paul Aubert to its Board of Directors

Mr. Aubert is currently the sole Shareholder at Paul Aubert PLLC.

February 5, 2018

·

2 min read

Policy

AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application (sNDA) for Feraheme (ferumoxytol injection)

This sNDA approval immediately doubles the number of patients who could benefit from Feraheme to include both CKD and non-CKD patients.

February 5, 2018

·

6 min read

BioCapital

McKesson Medical-Surgical to Offer New Sysmex Device That Provides Blood Test Results at Point of Care in Minutes

Once prepared for each day’s use, the Sysmex XW-100 allows health care professionals to provide patients with blood test results in as few as three minutes.

February 5, 2018

·

4 min read

Genetown

Dermatologic Surgery Publishes Clinical Data on Arch Therapeutics’ AC5 in a Topical Application

The authors report that in this single-blind study, wounds were randomized to receive AC5 or control treatment after sequential shave excision of two lesions in the same patient

February 5, 2018

·

6 min read

Chi-Med to Announce 2017 Final Results

Chi-Med will be announcing its final results for the year ended December 31, 2017 on Monday, March 12, 2018 at 7:00 am Greenwich Mean Time.

February 5, 2018

·

1 min read

Intellegens Secures First Commercial Contract for Alchemite Technology

The potential of Intellegens’ Alchemite AI technology has been demonstrated with the recent announcement of a commercial collaboration between the Cambridge-based company and e-Therapeutics.

February 5, 2018

·

2 min read